APPLICATION
ANDA083198
TYPE
ANDA
ORIGINAL APPROVAL
1972-12-27
LATEST ACTION
2010-04-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
LIDOCAINE HYDROCHLORIDEDiscontinued
LIDOCAINE HYDROCHLORIDE 2% · INJECTABLE · INJECTION
Approval history
2010-04-09Labeling · Supplement 26AP
2010-02-26Labeling · Supplement 25AP
2000-10-31Labeling · Supplement 19AP
1997-09-02Manufacturing (CMC) · Supplement 18AP
1997-03-05Manufacturing (CMC) · Supplement 16AP
1997-03-05Manufacturing (CMC) · Supplement 17AP
1997-03-05Manufacturing (CMC) · Supplement 15AP
1993-06-24Manufacturing (CMC) · Supplement 14AP
1992-04-06Manufacturing (CMC) · Supplement 11AP
1992-04-06Manufacturing (CMC) · Supplement 12AP
1991-02-20Labeling · Supplement 13AP
1989-02-16Labeling · Supplement 9AP
1988-09-20Labeling · Supplement 10AP
1986-06-09Manufacturing (CMC) · Supplement 7AP
1986-06-09Manufacturing (CMC) · Supplement 8AP
1982-06-14Manufacturing (CMC) · Supplement 4AP
1972-12-27OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.